The Brussels Desk · IndependentBrussels desk
Brussels Today
Markets live15:58 CET
  • EURO STOXX 50Index
    6,204.23+0.58%
  • DAXIndex
    25,622.61+0.95%
  • CAC 40Index
    7,956.7+0.28%
  • ASMLStock
    US$1,641.52-0.96%
  • SAPStock
    US$224.29-0.32%
  • AirbusStock
    €198.82+2.07%
  • BitcoinCrypto
    US$81,385.62-0.14%
  • EthereumCrypto
    US$2,421.70+0.07%
Lead storyEU Politics1h ago

Omnibus X: Brussels Bets It Can Cut Farm Red Tape Without Touching Food Safety

The Council's negotiating stance on the food and feed safety simplification package pairs pesticide residue limits at technical zero with longer approvals and a fast track for biocontrol, all under a year-end deadline.

Why it matters

The package is a study in giving with one hand and taking with the other. On the strict side, the Council wants pesticide residue limits for the most hazardous substances lowered to technical zero, and it would extend that rule to substances threatening honeybees and groundwater, hitting imports and domestic produce alike, with transitional provisions so compliant goods already on the market are not wasted. On the generous side, biocontrol substances would get a fast-track approval route, low-risk active substances would receive approvals without a fixed end date, and standard approvals would run 15 years at first and 25 on renewal. Test data protection stretches from 10 to 13 years, and to 15 for low-risk products, with a single EU-level database for test reports.

Brussels today

10 published today · updated just now

From the institutions

Commission · Parliament · Council

The Brussels Bubble

Institutional politics as practised, not as published.

All bubble reporting →

What It Means

One announcement, translated

A Tablet Instead of a Needle: EU Drug Watchdog Backs Eli Lilly’s Weight-Loss Pill

A positive scientific recommendation from the European Medicines Agency clears the biggest regulatory hurdle for an oral obesity treatment.

Europe’s pharmaceutical regulator has given its formal backing to an oral weight-loss treatment developed by Eli Lilly, paving the way for the pill to enter the single market. While the agency’s scientific committees pore over gigabytes of clinical data behind closed doors, their verdict is effectively the make-or-bre…

The Brief

Brussels, decoded, every morning. What happened, what it means, one good dry joke.